Small business innovative research phase i, proposal H252-001-0022, titled: microbeid: a point-of-care, electronics-free molecular diagnostic platform for microbial detection, medical research and…
Ended Purchase Order Awarded Last action
- Contract number
- HT942525PE013
- Awardee
-
Applied Nanotech, Inc. UEI HG7NJV44ZM65
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $249,962
Award facts
- Opportunity
-
- HQ003420RBDST Solicitation number
- Contract value 100% obligated
- $249,962.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 24 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Austin, TX 78754, USA
- Research
- SBIR Program Phase I Action
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency has awarded a $249,962.26 Small Business Innovation Research (SBIR) Phase I contract to Applied Nanotech, Inc., doing business as Fepet, for the development of MicroBeID, a point-of-care, electronics-free molecular diagnostic platform for microbial detection. The contract, issued as a firm fixed-price purchase order with an ultimate completion date of March 21, 2026, is designated as a total small business set-aside and supports medical research and development initiatives. Applied Nanotech, Inc., a woman-owned small business headquartered in Austin, Texas, was selected based on its established expertise in advanced technological innovation and prior success in securing federal research funding through SBIR and Small Business Technology Transfer (STTR) programs.
Applied Nanotech brings substantial credentials to this engagement, with a track record of delivering sophisticated research and development services to defense and federal agencies since its registration in SAM.gov in 2002. The company's experience spans flexible printed electronics, advanced manufacturing techniques, and sensor development—technical capabilities directly relevant to the development of innovative diagnostic platforms. Through this SBIR Phase I award, the company will conduct preliminary feasibility and technical merit assessment of the MicroBeID platform, which represents a significant advancement in portable molecular diagnostics for medical and defense applications. The contract positions Applied Nanotech to potentially advance to Phase II development if the Phase I research demonstrates sufficient promise and technical viability.
Description
Small business innovative research phase i, proposal H252-001-0022, titled: microbeid: a point-of-care, electronics-free molecular diagnostic platform for microbial detection, medical research and development contract.
Quick answers
Who was awarded contract HT942525PE013?
HT942525PE013 was awarded to Applied Nanotech, Inc. by Defense Health Agency (Department of Defense) on August 22, 2025.
How much is contract HT942525PE013 worth?
The government has obligated $249,962 on HT942525PE013.
Was contract HT942525PE013 competed?
The extent of competition for HT942525PE013 was full and open competition after exclusion of sources. The government received 24 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award